Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03276923 · ClinicalTrials.gov registry record
Maternal Autoimmune Disease Research Alliance (MADRA) Registry
A clinical trial of Rheumatoid Arthritis and Pregnancy Related, sponsored by Duke University.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT03276923 is a study of Rheumatoid Arthritis and Pregnancy Related that is actively recruiting participants, run by Duke University. The registered enrollment target is 1,000 participants, below the 4,686-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03276923, a study of Rheumatoid Arthritis and Pregnancy Related, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This multi-site registry, centered at Duke University, will enroll pregnant women with autoimmune and rheumatologic diseases. The main goal of MADRA is to identify ways to improve the health of women with rheumatic diseases and their babies during pregnancy. Prior studies demonstrate the importance of increase inflammation prior to and during pregnancy on these outcomes. The future research will seek to better define these risk factors and to identify ways to may improve them.
Conditions Studied
Study Locations (1)
North Carolina
- Duke University - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2018-01-01 |
| Est. Completion | 2027-01-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03276923
The ClinicalTrials.gov registry entry for NCT03276923 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,686-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (79% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 0 interventions.
NCT03276923 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT03276923 about?
NCT03276923 is a clinical study titled "Maternal Autoimmune Disease Research Alliance (MADRA) Registry". This multi-site registry, centered at Duke University, will enroll pregnant women with autoimmune and rheumatologic diseases. The main goal of MADRA is to identify ways to improve the health of women with rheumatic diseases and their babies during pregnancy. Prior studies demonstrate the importanc...
What is the current status of trial NCT03276923?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2018-01-01. Estimated completion is 2027-01-01.
What conditions does trial NCT03276923 study?
This clinical trial studies the following conditions: Rheumatoid Arthritis, Pregnancy Related, Systemic Lupus Erythematosus, Autoimmune Diseases, Scleroderma.
Who is sponsoring clinical trial NCT03276923?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03276923 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rheumatoid Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Rheumatology Diet Study
RECRUITING
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
Creating Health Course Study for People With Rheumatological Conditions
RECRUITING · NA
-
Physica System Total Knee Replacement Registry Study
RECRUITING · NA
-
Study of GS-0151 in Participants With Rheumatoid Arthritis
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.